SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report: September 6, 2002
Date of earliest event reported: September 6, 2002
Pfizer Inc.
(Exact name of registrant as specified in its charter)
|
Delaware (State or other jurisdiction of incorporation) |
1-3619 (Commission File Number) |
13-5315170 (I.R.S. Employer Identification No.) |
|
235 East 42nd Street New York, New York (Address of principal executive offices) |
10017 (Zip Code) |
Registrant's telephone number, including area code:
(212) 573-2323
Item 7(c). Exhibits
Exhibit 99 - Press Release of Pfizer Inc. dated September 6, 2002.
Item 9. Regulation FD Disclosure
On September 6, 2002, Pfizer Inc. issued a press release which is included as Exhibit 99 and is incorporated by reference.
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
|
|
PFIZER INC.
|
Dated: September 6, 2002
Exhibit Index
|
Exhibit No. |
Description |
|
99 |
Press Release dated September 6, 2002. |